Corticosteroid supplementation during cardiac arrest in rats

Area of Science:

• Cardiology
• Emergency Medicine
• Pharmacology

Background:

• Cardiac arrest remains a critical medical emergency with significant mortality.
• The efficacy of corticosteroids in improving resuscitation outcomes is not fully established.

Purpose of the Study:

• To investigate the effect of hydrocortisone on the rate of return of spontaneous circulation (ROSC) in a rat model of cardiac arrest.
• To assess the impact of hydrocortisone on cardiopulmonary resuscitation (CPR) duration and epinephrine requirements.

Main Methods:

• A prospective, blinded, randomized, placebo-controlled trial was conducted in 36 male Sprague-Dawley rats.
• Cardiac arrest was induced, followed by standardized CPR, mechanical ventilation, and administration of either placebo, 0.05 mg, or 0.25 mg of hydrocortisone.
• Continuous EKG and arterial blood pressure monitoring were employed.

Main Results:

• The group receiving 0.25 mg hydrocortisone (Group B) demonstrated a significantly higher resuscitation rate (92%) compared to the placebo and 0.05 mg hydrocortisone groups (50% each, P < 0.05).
• No statistically significant differences were observed in the duration of CPR or the amount of epinephrine used among the groups.
• A trend towards decreased CPR duration and epinephrine use was noted with hydrocortisone administration.

Conclusions:

• Hydrocortisone significantly increased the rate of ROSC in rats experiencing cardiac arrest.
• Further research is warranted to explore the mechanisms of action and long-term effects of hydrocortisone in cardiac arrest scenarios.